GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Piotroski F-Score

Mesa Laboratories (Mesa Laboratories) Piotroski F-Score : 6 (As of May. 01, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Mesa Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Mesa Laboratories's Piotroski F-Score or its related term are showing as below:

MLAB' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 7
Current: 6

During the past 13 years, the highest Piotroski F-Score of Mesa Laboratories was 7. The lowest was 3. And the median was 5.


Mesa Laboratories Piotroski F-Score Historical Data

The historical data trend for Mesa Laboratories's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Piotroski F-Score Chart

Mesa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 6.00 4.00 7.00

Mesa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 7.00 7.00 6.00 6.00

Competitive Comparison of Mesa Laboratories's Piotroski F-Score

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's Piotroski F-Score Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 0.611 + -0.549 + -1.23 + 2.116 = $0.9 Mil.
Cash Flow from Operations was 12.519 + 9.939 + 9.776 + 11.535 = $43.8 Mil.
Revenue was 55.591 + 50.645 + 53.165 + 53.473 = $212.9 Mil.
Gross Profit was 33.201 + 31.183 + 32.109 + 33.402 = $129.9 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(662.984 + 661.832 + 642.611 + 637.188 + 741.769) / 5 = $669.2768 Mil.
Total Assets at the begining of this year (Dec22) was $663.0 Mil.
Long-Term Debt & Capital Lease Obligation was $233.0 Mil.
Total Current Assets was $118.4 Mil.
Total Current Liabilities was $44.2 Mil.
Net Income was -1.784 + -1.438 + 1.306 + 0.451 = $-1.5 Mil.

Revenue was 58.879 + 50.453 + 58.749 + 54.287 = $222.4 Mil.
Gross Profit was 35.112 + 31.341 + 36.386 + 32.765 = $135.6 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(721.712 + 707.369 + 685.811 + 656.231 + 662.984) / 5 = $686.8214 Mil.
Total Assets at the begining of last year (Dec21) was $721.7 Mil.
Long-Term Debt & Capital Lease Obligation was $189.0 Mil.
Total Current Assets was $114.2 Mil.
Total Current Liabilities was $41.6 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Mesa Laboratories's current Net Income (TTM) was 0.9. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Mesa Laboratories's current Cash Flow from Operations (TTM) was 43.8. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=0.948/662.984
=0.0014299

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-1.465/721.712
=-0.0020299

Mesa Laboratories's return on assets of this year was 0.0014299. Mesa Laboratories's return on assets of last year was -0.0020299. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Mesa Laboratories's current Net Income (TTM) was 0.9. Mesa Laboratories's current Cash Flow from Operations (TTM) was 43.8. ==> 43.8 > 0.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=232.965/669.2768
=0.34808468

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=189.044/686.8214
=0.27524477

Mesa Laboratories's gearing of this year was 0.34808468. Mesa Laboratories's gearing of last year was 0.27524477. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=118.355/44.183
=2.67874522

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=114.185/41.617
=2.7437105

Mesa Laboratories's current ratio of this year was 2.67874522. Mesa Laboratories's current ratio of last year was 2.7437105. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Mesa Laboratories's number of shares in issue this year was 5.396. Mesa Laboratories's number of shares in issue last year was 5.36. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=129.895/212.874
=0.61019664

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=135.604/222.368
=0.60981796

Mesa Laboratories's gross margin of this year was 0.61019664. Mesa Laboratories's gross margin of last year was 0.60981796. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=212.874/662.984
=0.32108467

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=222.368/721.712
=0.30811182

Mesa Laboratories's asset turnover of this year was 0.32108467. Mesa Laboratories's asset turnover of last year was 0.30811182. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Mesa Laboratories has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Mesa Laboratories  (NAS:MLAB) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Mesa Laboratories Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines

From GuruFocus

MESA LABS DECLARES QUARTERLY DIVIDEND

By GuruFocusNews GuruFocusNews 07-06-2022

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

By Marketwired Marketwired 09-14-2021

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

By GuruFocusNews GuruFocusNews 07-07-2022

Mesa Labs Declares Quarterly Dividend

By Stock market mentor Stock market mentor 01-03-2023

Mesa Laboratories Inc (MLAB) CFO John Sakys Sold $570,893 of Shares

By GuruFocus Research GuruFocus Editor 12-11-2021

MESA LABS DECLARES QUARTERLY DIVIDEND

By Marketwired 10-03-2023